文献速递呼吸衰竭与机械通气消化、代谢与肾脏急症

血管性水肿

Angioedema.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论血管性水肿是危及生命的综合征,确保气道安全是最重要干预,随后根据疾病病理给予已确立及新型药物治疗。

本文是一篇以临床为重点的综述,描述血管性水肿综合征的遗传学、病理生理学、分类和治疗,重点介绍近期可用于急性治疗的新型药物。通过MEDLINE检索血管性水肿、获得性血管性水肿、遗传性血管性水肿III型及血管紧张素转换酶抑制剂诱导的血管性水肿相关文献,对诊断和管理信息进行总结。结论指出血管性水肿有多种亚型,各有不同病理生理,确保气道安全是最重要干预,随后根据疾病病理给予已确立及新型药物治疗。

要点

  • 血管性水肿是危及生命的综合征,有多种亚型,各有不同病理生理。
  • 确保气道安全是最重要的干预措施。
  • 在确保气道安全后,根据疾病病理给予已确立及新型药物治疗。
  • 近年来对血管性水肿综合征的机制理解有所提高,新型药物可改善结局。
  • 本文提供基于证据的各类血管性水肿亚型诊断和 suggested 管理方法。

处置流程与药物剂量

  • 确保气道安全是最重要的干预措施。
  • 在确保气道安全后,根据疾病病理给予已确立及新型药物治疗。

研究设计与关键结果

  • 本文为以临床为重点的综述,通过MEDLINE检索血管性水肿、获得性血管性水肿、遗传性血管性水肿III型及血管紧张素转换酶抑制剂诱导的血管性水肿相关文献,检索并回顾综述、指南、临床试验、病例系列等出版物及其参考文献。
  • 对相关出版物数据进行回顾、总结和综合,用于描述各类血管性水肿综合征诊断和管理的现状。
  • 结论:血管性水肿是危及生命的综合征,有多种亚型,各有不同病理生理;本文提供基于证据的各类亚型诊断和 suggested 管理方法;确保气道安全是最重要干预,随后根据疾病病理给予已确立及新型药物治疗。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,血管性水肿患者应首先确保气道安全,然后根据疾病病理给予已确立及新型药物治疗。
  • 作者认为,近年来对血管性水肿综合征机制理解的提高和新型药物的可用性可改善这些综合征的结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Angioedema is a potentially life-threatening occurrence that is encountered by critical care providers. The mechanistic understanding of angioedema syndromes has improved in recent years, and novel medications are available that improve outcomes from these syndromes. This clinically focused review will describe the underlying genetics, pathophysiology, classification and treatment of angioedema syndromes, with an emphasis on the novel pharmacologic agents that have recently become available for acute treatment.

DATA SOURCES: A MEDLINE search was conducted with the MeSH terms angioedema, acquired angioedema, hereditary angioedema type III, and angiotensin converting enzyme inhibitor-induced angioedema.

STUDY SELECTION: Selected publications describing angioedema, clinical trials, diagnosis, management, and genetics were retrieved (reviews, guidelines, clinical trials, case series), and their bibliographies were also reviewed to identify relevant publications.

DATA EXTRACTION: Data from the relevant publications were reviewed, summarized and the information synthesized.

DATA SYNTHESIS: The data obtained were used to describe the current state of diagnosis and management of various angioedema syndromes.

CONCLUSIONS: Angioedema is a life-threatening syndrome with multiple subtypes, each with a distinct pathophysiology. We present an evidence-based approach to the diagnosis and suggested management of various subtypes of angioedema. Securing the airway remains the most important intervention, followed by administration of both established and more novel pharmacologic interventions based on disease pathology.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. LoVerde D, Files DC, Krishnaswamy G, et al. Angioedema. Crit Care Med. 2017. PMID: 28291095. doi:10.1097/CCM.0000000000002281

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。